If you think the market is just driven by scientists in white coats, think again! Patient advocacy groups are the real MVPs here. These are the people—patients and their families—who lobby governments, raise money for research, and keep the pressure on pharma companies to keep innovating. For a long time, blood disorders like Sickle Cell didn't get much funding, but thanks to these...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt